Stockreport

Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device

Organon & Co.  (OGN) 
PDF MIUDELLA® is a strategic addition to Organon’s portfolio, strengthening its long-term commitment to advancing women’s health JERSEY CITY, N.J.--(BUSINESS WIRE)--Organ [Read more]